Cardiac personalized medicine represents a groundbreaking approach to cardiovascular care, tailoring treatment strategies to an individual's unique genetic makeup, lifestyle factors, and specific cardiac conditions. This emerging field aims to revolutionize how we prevent, diagnose, and treat cardiovascular diseases by recognizing the inherent variability among patients. By leveraging advances in genetics, biomarkers, and diagnostic technologies, cardiac personalized medicine strives to deliver more precise and effective interventions, ultimately improving patient outcomes. This approach holds the promise of ushering in a new era of cardiovascular healthcare that is not only more targeted but also more patient-centric, taking into account the diverse factors that contribute to heart health on an individualized level. As research and technology continue to advance, the prospects for enhancing cardiac care through personalized medicine remain both exciting and full of potential.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation